{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:32:49Z","timestamp":1782397969535,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12272-016-0728-6","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T11:03:05Z","timestamp":1457521385000},"page":"565-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of candesartan cilexetil and amlodipine orotate on receptor for advanced glycation end products expression in the aortic wall of Otsuka Long-Evans Tokushima Fatty (OETFF) type 2 diabetic rats"],"prefix":"10.1007","volume":"39","author":[{"given":"Min-Kyu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Baek","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok-Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Ihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Bae","family":"Seung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"728_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20100501","volume":"121","author":"DP Barlovic","year":"2011","unstructured":"Barlovic DP, Soro-Paavonen A, Jandeleit-Dahm KA (2011) RAGE biology, atherosclerosis and diabetes. Clin Sci (Lond) 121:43\u201355","journal-title":"Clin Sci (Lond)"},{"key":"728_CR2","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","volume":"50","author":"A Bierhaus","year":"2001","unstructured":"Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Kloting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Haring HU, Schleicher E, Nawroth PP (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792\u20132808","journal-title":"Diabetes"},{"key":"728_CR3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820","journal-title":"Nature"},{"key":"728_CR4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1681\/ASN.2008050514","volume":"20","author":"MT Coughlan","year":"2009","unstructured":"Coughlan MT, Thorburn DR, Penfold SA, Laskowski A, Harcourt BE, Sourris KC, Tan AL, Fukami K, Thallas-Bonke V, Nawroth PP, Brownlee M, Bierhaus A, Cooper ME, Forbes JM (2009) RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol 20:742\u2013752","journal-title":"J Am Soc Nephrol"},{"key":"728_CR5","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/ndt\/gfh499","volume":"19","author":"Q Fan","year":"2004","unstructured":"Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y (2004) Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK\/Ta mice. Nephrol Dial Transplant 19:3012\u20133020","journal-title":"Nephrol Dial Transplant"},{"key":"728_CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pharmthera.2009.06.013","volume":"124","author":"DG Farmer","year":"2009","unstructured":"Farmer DG, Kennedy S (2009) RAGE, vascular tone and vascular disease. Pharmacol Ther 124:185\u2013194","journal-title":"Pharmacol Ther"},{"key":"728_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597\u2013605","journal-title":"Circulation"},{"key":"728_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2009.01.036","volume":"206","author":"SH Ihm","year":"2009","unstructured":"Ihm SH, Lee JO, Kim SJ, Seung KB, Schini-Kerth VB, Chang K, Oak MH (2009) Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 206:47\u201353","journal-title":"Atherosclerosis"},{"key":"728_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00395-009-0071-x","volume":"105","author":"SH Ihm","year":"2010","unstructured":"Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105:399\u2013407","journal-title":"Basic Res Cardiol"},{"key":"728_CR10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"J-A Kim","year":"2006","unstructured":"Kim J-A, Montagnani M, Koh K, Quon M (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888\u20131904","journal-title":"Circulation"},{"key":"728_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","volume":"140","author":"K Koh","year":"2010","unstructured":"Koh K, Quon M, Han S, Lee Y, Kim S, Koh Y, Shin E (2010) Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol 140:73\u201381","journal-title":"Int J Cardiol"},{"key":"728_CR12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","volume":"164","author":"JH Li","year":"2004","unstructured":"Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY (2004) Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway. Am J Pathol 164:1389\u20131397","journal-title":"Am J Pathol"},{"key":"728_CR13","doi-asserted-by":"crossref","first-page":"e35016","DOI":"10.1371\/journal.pone.0035016","volume":"7","author":"Y Li","year":"2012","unstructured":"Li Y, Liu S, Zhang Z, Xu Q, Xie F, Wang J, Ping S, Li C, Wang Z, Zhang M, Huang J, Chen D, Hu L, Li C (2012) RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation. PLoS ONE 7:e35016","journal-title":"PLoS ONE"},{"key":"728_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(01)00729-8","volume":"165","author":"RP Mason","year":"2002","unstructured":"Mason RP (2002) Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence. Atherosclerosis 165:191\u2013199","journal-title":"Atherosclerosis"},{"key":"728_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbrc.2009.05.061","volume":"385","author":"T Matsui","year":"2009","unstructured":"Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S (2009) Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 385:269\u2013272","journal-title":"Biochem Biophys Res Commun"},{"key":"728_CR16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2009.07.004","volume":"61","author":"T Matsui","year":"2010","unstructured":"Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S (2010) Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression. Pharmacol Res 61:34\u201339","journal-title":"Pharmacol Res"},{"key":"728_CR17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/01.RES.82.12.1298","volume":"82","author":"FJ Miller Jr","year":"1998","unstructured":"Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82:1298\u20131305","journal-title":"Circ Res"},{"key":"728_CR18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/cs1000543","volume":"100","author":"S Miller","year":"2001","unstructured":"Miller S, Walker SW, Arthur JR, Nicol F, Pickard K, Lewin MH, Howie AF, Beckett GJ (2001) Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci (Lond) 100:543\u2013550","journal-title":"Clin Sci (Lond)"},{"key":"728_CR19","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1097\/01.ASN.0000032418.67267.F2","volume":"13","author":"T Miyata","year":"2002","unstructured":"Miyata T, De Strihou CVY, Ueda Y, Ichimori K, Inagi R, Onogi H, Ishikawa N, Nangaku M, Kurokawa K (2002) Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 13:2478\u20132487","journal-title":"J Am Soc Nephrol"},{"key":"728_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdiacomp.2012.07.006","volume":"27","author":"M Morita","year":"2013","unstructured":"Morita M, Yano S, Yamaguchi T, Sugimoto T (2013) Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells. J Diabetes Complications 27:11\u201315","journal-title":"J Diabetes Complications"},{"key":"728_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mvr.2005.10.002","volume":"70","author":"K Nakamura","year":"2005","unstructured":"Nakamura K, Yamagishi S, Nakamura Y, Takenaka K, Matsui T, Jinnouchi Y, Imaizumi T (2005) Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc Res 70:137\u2013141","journal-title":"Microvasc Res"},{"key":"728_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/CS20050067","volume":"109","author":"R Ray","year":"2005","unstructured":"Ray R, Shah AM (2005) NADPH oxidase and endothelial cell function. Clin Sci (Lond) 109:217\u2013226","journal-title":"Clin Sci (Lond)"},{"key":"728_CR23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.vph.2012.02.012","volume":"56","author":"A Schramm","year":"2012","unstructured":"Schramm A, Matusik P, Osmenda G, Guzik TJ (2012) Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 56:216\u2013231","journal-title":"Vascul Pharmacol"},{"key":"728_CR24","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","volume":"109","author":"M Schupp","year":"2004","unstructured":"Schupp M, Janke J, Clasen R, Unger T, Kintscher U (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109:2054\u20132057","journal-title":"Circulation"},{"key":"728_CR25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.0000036448.44066.53","volume":"40","author":"A Sharma","year":"2002","unstructured":"Sharma A, Janke J, Gorzelniak K, Engeli S, Luft F (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 40:609\u2013611","journal-title":"Hypertension"},{"key":"728_CR26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1291\/hypres.27.877","volume":"27","author":"S Umemoto","year":"2004","unstructured":"Umemoto S, Tanaka M, Kawahara S, Kubo M, Umeji K, Hashimoto R, Matsuzaki M (2004) Calcium antagonist reduces oxidative stress by upregulating Cu\/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 27:877\u2013885","journal-title":"Hypertens Res"},{"key":"728_CR27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.lfs.2003.10.040","volume":"75","author":"JM Wang","year":"2004","unstructured":"Wang JM, Wang Y, Zhu ZS, Zhang MC, Zou Y, Li JJ, Li MJ, Jiang XJ, Li XY (2004) Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats. Life Sci 75:407\u2013420","journal-title":"Life Sci"},{"key":"728_CR28","first-page":"169","volume":"30","author":"S Yamagishi","year":"2004","unstructured":"Yamagishi S, Takeuchi M (2004) Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. Drugs Exp Clin Res 30:169\u2013175","journal-title":"Drugs Exp Clin Res"},{"key":"728_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mvr.2007.05.001","volume":"75","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Matsui T, Nakamura K, Inoue H, Takeuchi M, Ueda S, Fukami K, Okuda S, Imaizumi T (2008a) Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression. Microvasc Res 75:130\u2013134","journal-title":"Microvasc Res"},{"key":"728_CR30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1517\/13543784.17.7.983","volume":"17","author":"S Yamagishi","year":"2008","unstructured":"Yamagishi S, Nakamura K, Matsui T, Ueda S, Fukami K, Okuda S (2008b) Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications. Expert Opin Investig Drugs 17:983\u2013996","journal-title":"Expert Opin Investig Drugs"},{"key":"728_CR31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbagen.2011.03.014","volume":"1820","author":"S Yamagishi","year":"2012","unstructured":"Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S (2012) Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta 1820:663\u2013671","journal-title":"Biochim Biophys Acta"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-016-0728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-016-0728-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-016-0728-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:57:47Z","timestamp":1559458667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-016-0728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s12272-016-0728-6","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}